株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

注入型ドラッグデリバリー装置の世界市場の将来予測

Injectable Drug Delivery Market: By Devices (Auto Drug Injecting, Pen Injectors, Others); By Drug Formulations (Conventional, Novel ); By Therapeutic Area (Hormonal Disorders, Oncology, Auto-Immune, Others); By Geography - 2018 - 2023

発行 IndustryARC 商品コード 622518
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.87円で換算しております。
Back to Top
注入型ドラッグデリバリー装置の世界市場の将来予測 Injectable Drug Delivery Market: By Devices (Auto Drug Injecting, Pen Injectors, Others); By Drug Formulations (Conventional, Novel ); By Therapeutic Area (Hormonal Disorders, Oncology, Auto-Immune, Others); By Geography - 2018 - 2023
出版日: 2018年12月17日 ページ情報: 英文
概要

当レポートでは、世界の注入型ドラッグデリバリー装置の市場について分析し、全体的な市場構造や背景事情、主な市場促進・抑制要因、製品種類別 (装置、剤型)・疾患別・地域別の市場動向見通し、市場競争の情勢、昨今の資本取引・戦略展開の動き、主要企業のプロファイルなどについて調査しております。

第1章 市場概要

第2章 エグゼクティブ・サマリー

第3章 市場環境

  • 市場シェア分析
  • 比較分析
    • 製品の相互比較
    • エンドユーザーのプロファイル
    • 特許分析
    • 上位5社の財務分析

第4章 世界の注入式ドラッグデリバリー装置市場:市場への影響要因

  • 市場促進要因
  • 市場抑制要因
  • 市場の課題
  • 市場の求心力:ポーターのファイブフォース分析

第5章 世界の注入式ドラッグデリバリー装置市場:戦略分析

  • バリューチェーン分析
  • 市場機会の分析
  • 製品/市場ライフサイクルの分析

第6章 世界の注入式ドラッグデリバリー装置市場:種類別

  • 医薬品の剤型方法
  • 装置別
    • 従来型の装置
    • 自動注射装置
    • 自己注射装置
    • ペン型注射器
    • ニードルフリー注射装置
  • その他

第7章 世界の注入式ドラッグデリバリー装置市場:疾患の種類別

  • 貧血症
  • 糖尿病
  • 多発性硬化症
  • リウマチ
  • クローン病
  • その他

第8章 世界の注入式ドラッグデリバリー装置市場:地域別

  • イントロダクション
  • 北米 (カナダ、ハイチ、メキシコ、米国など)
  • 中南米 (アルゼンチン、ブラジル、チリ、コロンビア、ベネズエラなど)
  • 欧州 (ドイツ、フランス、イタリア、ロシア、スペイン、トルコ、英国など)
  • アジア太平洋地域 (バングラデシュ、中国、インド、ネパール、スリランカ、シンガポール、マレーシアなど)
  • 他の国々 (RoW)

第9章 市場のエントロピー (市場変化の方向性)

  • 新製品の発売
  • 企業合併・買収 (M&A)、事業提携・協力、合弁事業 (JV)

第10章 企業プロファイル (概要、財務分析、SWOT分析、近年の動向、製品ポートフォリオ)

  • Becton Dickinson and Company (BD)
  • Baxter International Inc.
  • Consort Medical PLC
  • Crossject SA
  • Eli Lilly and Company
  • Elcam Medical
  • Novo Nordisk
  • Owen Mumford Ltd
  • Sanofi
  • Schott AG
  • テルモ
  • Ypsomed Holding AG
  • その他

第11章 付録

目次

The global injectable drug delivery market is $15.7B in 2017 and is estimated to grow at a CAGR of 8.53% during 2018-2023. Conventional injection devices holds the highest market share with 87% and generated revenue of 13.1B and is projected to grow with a CAGR of 7.37%. Changing healthcare models, a growing number of patients are driving the injectable drug delivery market.

What is Injectable drug delivery?

Injectable drug delivery is the injection of drugs in the patient's body using a delivery device. With this it has become relatively easy allowing patients to administer drugs at home without medical assistance.

What are the major applications for Injectable drug delivery?

Injectable drug delivery is majorly used for different conditions that include hepatitis C, cystic fibrosis, pain, autoimmune diseases, Wilson's disease, hormonal imbalance, hemophilia, and ribose-5-phosphate isomerase deficiency. It also helps in administering drugs in unconscious and comatose patients.

Market Research and Market Trends of Injectable drug delivery

Advancements in technological processes have resulted in the generation of improved and enhanced devices, as well as equipment that is tailor-made and specific to different categories of patient care. In addition, technological innovations like dual-injectable have further enhanced the method of drug delivery and the development of the biologics market has led to an increase in the demand for these injectable.

SmartDose platform is designed to easily integrate into a patient's lifestyle. The single-use, electronic wearable injector stick to the patient's body usually on the abdomen. It was designed for patient comfort and simplicity.

Component manufacturers continue to develop sophisticated packaging components and delivery systems to support the requirements of complex drug products. Drive toward cleaner and more secure primary containment systems that avoid interaction with the drug product and maintain the drug product's purity and effectiveness over time.

Who are the Major Players in Injectable drug delivery market?

The companies referred in the market research report includes Baxter international, Terumo Corp, Schott AG, SHL group, Owen Mumford ltd, Sanofi, Novo nordix.

What is our report scope?

The report incorporates in-depth assessment of the competitive landscape, product market sizing, product benchmarking, market trends, product developments, financial analysis, strategic analysis and so on to gauge the impact forces and potential opportunities of the market. Apart from this the report also includes a study of major developments in the market such as product launches, agreements, acquisitions, collaborations, mergers and so on to comprehend the prevailing market dynamics at present and its impact during the forecast period 2018-2024.

All our reports are customizable to your company needs to a certain extent, we do provide 20 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.

Key Takeaways from this Report

Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.

Understand the different dynamics influencing the market - key driving factors, challenges and hidden opportunities.

Get in-depth insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.

Analyze the sales and distribution channels across key geographies to improve top-line revenues.

Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.

Get a quick outlook on the market entropy - M's, deals, partnerships, product launches of all key players for the past 4 years.

Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.

1. Market Overview

2. Executive Summary

3. Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
    • 3.2.1. Product Benchmarking
    • 3.2.2. End user profiling
    • 3.2.3. Patent Analysis
    • 3.2.4. Top 5 Financials Analysis

4. Global Injectable Drug Delivery - Market Forces

  • 4.1. Market Drivers
    • 4.1.1. Inherent Use Case Scenario of IDD Devices With Biologics
    • 4.1.2. Increase in Global Diabetic Population and Usage of Insulin Pens
    • 4.1.3. Others
  • 4.2. Market Constraints
    • 4.2.1. Infection Risks And Government Laws
    • 4.2.2. Others
  • 4.3. Market Challenges
    • 4.3.1. Higher Manufacturing Standards Needed to Avoid Product Recalls
    • 4.3.2. Others
  • 4.4. Attractiveness of the Industry
    • 4.4.1. Power of Suppliers
    • 4.4.2. Power of Customers
    • 4.4.3. Threat of New entrants
    • 4.4.4. Threat of Substitution
    • 4.4.5. Degree of Competition

5. Global Injectable Drug Delivery Market- Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Opportunities Analysis
  • 5.3. Product/Market Life Cycle Analysis

6. Global Injectable Drug Delivery Market - By Type

  • 6.1. Pharmaceutical Drug Formulations
  • 6.2. By Device
    • 6.2.1. Conventional Devices
    • 6.2.2. Auto Injector Devices
    • 6.2.3. Self Injector Devices
    • 6.2.4. Pen Injectors
    • 6.2.5. Needle Free Injector Devices
  • 6.3. Others

7. Global Injectable Drug Delivery Market - By Type of Diseases

  • 7.1. Anemia
  • 7.2. Diabetes
  • 7.3. Multiple sclerosis
  • 7.4. Rheumatoid
  • 7.5. Crohn's
  • 7.6. Others

8. Global Injectable Drug Delivery Market -Geographic Analysis

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. Canada
    • 8.2.2. Haiti
    • 8.2.3. Mexico
    • 8.2.4. USA
    • 8.2.5. Others
  • 8.3. South & Central America
    • 8.3.1. Argentina
    • 8.3.2. Brazil
    • 8.3.3. Chile
    • 8.3.4. Colombia
    • 8.3.5. Venezuela
    • 8.3.6. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. Italy
    • 8.4.4. Russia
    • 8.4.5. Spain
    • 8.4.6. Turkey
    • 8.4.7. U.K
    • 8.4.8. Others
  • 8.5. APAC
    • 8.5.1. Bangladesh
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Nepal
    • 8.5.5. Srilanka
    • 8.5.6. Singapore
    • 8.5.7. Malaysia
    • 8.5.8. Others
  • 8.6. ROW

9. Market Entropy

  • 9.1. New Product Launches
  • 9.2. M&As, Collaborations, JVs and Partnerships

10. Company Profiles (Overview, Financials, SWOT Analysis - Top 5 Companies, Developments, Product Portfolio)

  • 10.1. Becton Dickinson and Company (BD)
  • 10.2. Baxter International Inc.
  • 10.3. Consort Medical PLC
  • 10.4. Crossject SA
  • 10.5. Eli Lilly and Company
  • 10.6. Elcam Medical
  • 10.7. Novo Nordisk
  • 10.8. Owen Mumford Ltd
  • 10.9. Sanofi
  • 10.10. Schott AG
  • 10.11. Terumo Corporation
  • 10.12. Ypsomed Holding AG
  • 10.13. Others

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

11. Appendix

  • 11.1. Abbreviations
  • 11.2. Sources
  • 11.3. Research Methodology
  • 11.4. Bibliography
  • 11.5. Compilation of Expert Insights
  • 11.6. Disclaimer
Back to Top